Meilan wants to consolidate its position as a giant of generic drugs: to acquire hikma for us $7 billion

Source: reprinted on January 30, 2015, it was reported that American generic giant mylan planned to acquire Jordan pharmaceutical company hikma with USD 7 billion For mylan, it's the best time to buy hikma for $7 billion: hikma's generic colchicine has just been approved by the FDA Another factor of concern is a representative pharmaceutical company in the Arab world Hikma, a Jordanian pharmaceutical company, was acquired? The news has been circulating for a long time, not without cause: its sales scale and factory facilities in emerging markets are coveted, and the gout drug mitigare is even more attractive So, American generics giant mylan came to us with $7 billion in cash Hikma company was founded in 1978, mainly engaged in generic medicine business, and became the first Arab company to obtain FDA certification in 1996 The first factory is built in Italy Except for the United States and Europe, the company sells products in Portugal, Arabia, Morocco, the Middle East and North Africa In 2005, the company was listed on the London Stock Exchange, and then in 2007, it acquired German tumor drug injection contract manufacturer thymoorgan In 2011, the company acquired the multi-source injectables business from Baite On January 28, the company's market value was about £ 4.67 billion In the first half of 2014, the company's main business income was $738 million, up 16% year on year, and its net profit was $169 million, up 132% year on year For mylan, it's the best time to buy hikma for $7 billion: hikma's generic colchicine has just been approved by the FDA There is also a factor of concern This is a representative pharmaceutical company in the Arab world Can mylan get married successfully?